Recombinant adenovirus encoding gp100 modulates experimental melanin- protein induced uveitis (EMIU)

Journal of Autoimmunity

Volumn 11, Issue 2, 1998, Pages 111-118

  Chan, Chi Chao ^a   Li, Ying ^a   Sun, Bing ^a   Li, Qian ^a   Matteson, Dawn M ^a   Shen, De Fen ^a   Nussenblatt, Robert B ^a   Zhai, Yifan ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Antigen specific melanoma vaccine; Bovine melanin protein (BMP); Experimental melanin protein induced uveitis (EMIU); Interleukin 12p40; Recombinant adenovirus encoding gp100

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UVEITIS; VIRUS RECOMBINANT;

EID: 0031777381     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0187     Document Type: Article

References (52)

1. Vennegoor C., Hageman P., Van Nouhuijs H., Ruiter D.J., Calafat J., Ringens P.J., Rumeke P. 1988. A monoclonal antibody specific for cells of the melanocyte lineage. Am. J. Pathol. 130: 179-192
2. Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Sakaguchi K., Appella E., Yannelli J.R., Adema G.J., Miki T., Rosenberg S.A. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91: 6458-6462
3. Kawakami Y., Eliyahu S., Jennings C., Sakaguchi K., Kang X., Southwood S., Robbins P.F., Sette A., Appella E., Rosenberg S.A. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154: 3961-3968
4. Adema G.J., de Boer A.J., Vogel A.M., Loenen W.A.M., Figdor C.G. 1994. Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269: 20126-20133
5. Salgaller M.L., Afshar A., Marincola F.M., Rivoltini L., Kawakami Y., Rosenberg S.A. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res. 55: 4972-4979
6. Bakker A.B., Schreurs M.W., de Boer A.J., Kawakami Y., Rosenberg S.A., Adema G.J., Figdor C.G. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179: 1005-1009
7. Zhai Y., Yang J.C., Kawakami Y., Spiess P., Wadsworth S.C., Cardoza L.M., Couture L.A., Smith A.E., Rosenberg A.A. 1996. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J. Immunol. 156: 700-710
8. Kawakami Y., Robbins P.F., Rosenberg S.A. 1996. Human melanoma antigens recognized by T lymphocytes. Keio. J. Med. 45: 100-108
9. Cox A.L., Skipper J., Chen Y., Henderson R.A., Darrow T.L., Shabanowitz J., Engelhard V.H., Hunt D.F., Slingluff C.L. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716-719
10. Rosenberg S.A. 1997. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18: 175-182
11. Broekhuyse R.M., Kuhlmann E.D., Winkens H.J., Van Vugt A.H.M. 1991. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble intrinsic protein fraction of the retinal pigment epithelium. Exp. Eye Res. 52: 465-474
12. Chan C.C., Hikita N., Dastgheib K., Whitcup S.M., Gery I., Nussenblatt R.B. 1994. Experimental melanin-protein-induced uveitis in the Lewis rat. Immunopathologic processes. Ophthalmology 101: 1275-1280
13. Bora N.S., Kim M.C., Kabeer N.H., Simpson S.C., Tandhasetti M.T., Cirrito T.P., Kaplan A.D., Kaplan H.J. 1995. Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest. Ophthalmol. Vis. Sci. 36: 1056-1066
14. Broekhuyse R.M., Kuhlmann E.D. 1993. Experimental autoimmune anterior uveitis. The preparation of uveitogenic ocular melanin. Invest. Ophthalmol. Vis. Sci. 34: 698-700
15. Chan C.C., Dastgheib K., Hikita N., Walton R.C., Nussenblatt R.B., Broekuyse R.M. 1994. Experimental melanin-protein induced uveitis ('EMIU', formerly 'EAAU'): immunopathology, susceptibility and therapy. In Advances in Ocular Immunology. R.B. Nussenblatt, S.M. Whitcup, R. R. Caspi, I. Gery, eds. Elsevier Science B.V. pp. 91-94
16. Broekhuyse R.M., Winkens H.J., Kuhlmann E.D. 1995. Multiple recurrences in melanin-protein induced uveitis in the rat. Ocul. Immunol. Inflam. 3: 149-156
17. Adorini L., Sinigaglia F. 1997. Pathogenesis and immunotherapy of autoimmune diseases. Immunol. Today 18: 209-211
18. Li Q., Sun B., Dastgheib K., Chan C.C. 1996. Suppressive effect of transforming growth factor β1 on the recurrence of experimental melanin protein-induced uveitis: upregulation of ocular interleukin-10. Clin. Immunol. Immunopathol. 81: 55-61
19. Sun B., Wells J., Goldmuntz E., Silver P., Remmers E.F., Wilder R.L., Caspi R.R. 1996. A simplified, competitive RT-PCR method for measuring rat IFN-γ mRNA expression. J. Immunol. Meth. 195: 139-148
20. Kobayashi T., Urabe K., Orlow S.J., Higashi K., Imokawa G., Kwon B.S., Potterf B., Hearing V.J. 1994. The Pmel 17/silver locus protein: characterization and investigation of its melanogenic function. J. Biol. Chem. 269: 29198-29205
21. Schreier H. 1994. The new frontier: gene and oligonucleotide therapy. Pharm. Acta Helv. 68: 145-159
22. Rich D.P., Couture L.A., Cardoza L.M., Guiggio V.M., Armentano D., Espino P.C., Hehir K., Welsh M.J., Smith A.E., Gregory R.J. 1993. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum. Gene Ther. 4: 461-476
23. Welsh M.J., Smith A.E., Zabner J., Rich D.P., Graham S.M., Gregory R.J., Pratt B.M., Moscicki R.A. 1994. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5: 209-219
24. Chen S.J., Wilson J.M., Muller D.W. 1994. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89: 1922-1928
25. Eisensmith R.C., Woo S.L. 1996. Gene therapy for phenylketonuria. Eur. J. Pediatr. 155 (Suppl 1): S16-S19
26. Setoguchi Y., Jaffe H.A., Chu C.S., Crystal R.G. 1994. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. Am. J. Respir. Cell. Mol. Biol. 10: 369-377
27. Chen P.W., Wang M., Bronte V., Zhai Y., Rosenberg S.A., Restifo N.P. 1996. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156: 224-231
28. Zhai Y., Yang J.C., Spiess P., Nishimura M.I., Overwijk W.W., Roberts B., Restifo N.P., Rosenberg S.A. 1997. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J. Immunotherapy 20: 15-25
29. Li Y., Zhai Y., Li Q., Nussenblatt R.B., Chan C.C. 1996. Gp100, a melanocyte-lineage antigen, enhances experimental melanin-protein induced uveitis (EMIU). Invest. Ophthalmol. Vis. Sci. 37: S539
30. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., Maclaren N. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95: 628-634
31. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252-10256
32. Daniel D., Wegmann D.R. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 93: 956-960
33. Bach J.-F., 1997. Tolerance and uveitis [Editorial]. Am. J. Ophthalmol. 123: 684-687
34. Nussenblatt R.B., Caspi R.R., Mahdi R., Chan C.C., Roberge F., Lider O., Weiner H.L. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144: 1689-1695
35. Thurau S.R., Chan C.C., Suh E., Nussenblatt R.B. 1991. Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J. Autoimmunity 4: 507-516
36. Rizzo L.V., Miller-Rivero N.E., Chan C.C., Wiggert B., Nussenblatt R.B., Caspi R.R. 1994. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Immunol. 94: 1668-1672
37. Gregerson D.S., Obritsch W.F., Donoso L.A. 1993. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J. Immunol. 151: 5751-5761
38. Dick A.D., Cheng Y.F., Liversidge J., Forrester J.V. 1994. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology 82: 625-631
39. Li Q., Sun B., Luyo D., Caspi R.R., Chan C.C. 1996. Cytokine profile of experimental melanin-protein induced uveitis (EMIU): expression and kinetics. Invest. Ophthalmol. Vis. Sci. 37: S538
40. Rizzo L.V., Caspi R.R. 1995. Immunotolerance and prevention of ocular autoimmune disease. Curr. Eye Res. 14: 857-864
41. Lamont A.G., Bruce M.G., Watret K.C., Ferguson A. 1988. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 64: 135-139
42. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845
43. Trinchieri G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13: 251-276
44. Chan S.H., Kobayashi M., Santoli D., Perussia B., Trinchieri G. 1992. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148: 92-98
45. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages [see comments]. Science 260: 547-549
46. Waldburger K.E., Hastings R.C., Schaub R.G., Goldman S.J., Leonard J.P. 1996. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am. J. Pathol. 148: 375-382
47. Leonard J.P., Waldburger K.E., Goldman S.J. 1996. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann. N. Y. Acad. Sci. 795: 216-226
48. Germann T., Szeliga J., Hess H., Storkel S., Podlaski F.J., Gately M.K., Schmitt E., Rude E. 1995. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92: 4823-4827
49. Yokoi H., Kato K., Kezuka T., Sakai J., Usui M., Yagita H., Okumura K. 1997. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur. J. Immunol. 27: 641-646
50. McIntyre K.W., Shuster D.J., Gillooly K.M., Warrier R.R., Connaughton S.E., Hall L.B., Arp L.H., Gately M.K., Magram J. 1996. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26: 2933-2938
51. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., Strober W. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281-1290
52. Sun B., Rizzo L.V., Sun S.H., Chan C.C., Wiggert B., Wilder R.L., Caspi R.R. 1997. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J. Immunol. 159: 1004-1011